from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: Dianthus Therapeutics, Inc. /DE/ quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
Dianthus Therapeutics, Inc. /DE/ Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 38,617,580, a 16% increase year-over-year.
Dianthus Therapeutics, Inc. /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 38,617,580, a 16% increase from 2024.
Dianthus Therapeutics, Inc. /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 33,313,849, a 546% increase from 2023.
Dianthus Therapeutics, Inc. /DE/ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 5,153,423, a 489% increase from 2022.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	38,617,580	+5,303,731	+16%	01 Oct 2025	31 Dec 2025	10-K	09 Mar 2026	2025	FY
Q3 2025	37,794,088	+3,557,360	+10%	01 Jul 2025	30 Sep 2025	10-Q	05 Nov 2025	2025	Q3
Q2 2025	35,822,308	+1,595,270	+4.7%	01 Apr 2025	30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	35,790,700	+10,125,225	+39%	01 Jan 2025	31 Mar 2025	10-Q	12 May 2025	2025	Q1
Q4 2024	33,313,849	+28,160,426	+546%	01 Oct 2024	31 Dec 2024	10-K	09 Mar 2026	2025	FY
Q3 2024	34,236,728	+30,329,842	+776%	01 Jul 2024	30 Sep 2024	10-Q	05 Nov 2025	2025	Q3
Q2 2024	34,227,038	+33,352,138	+3812%	01 Apr 2024	30 Jun 2024	10-Q	07 Aug 2025	2025	Q2
Q1 2024	25,665,475	+24,790,766	+2834%	01 Jan 2024	31 Mar 2024	10-Q	12 May 2025	2025	Q1
Q4 2023	5,153,423	+4,279,189	+489%	01 Oct 2023	31 Dec 2023	10-K	11 Mar 2025	2024	FY
Q3 2023	3,906,886	+3,032,559	+347%	01 Jul 2023	30 Sep 2023	10-Q	07 Nov 2024	2024	Q3
Q2 2023	874,900	-57,940,643	-99%	01 Apr 2023	30 Jun 2023	10-Q	08 Aug 2024	2024	Q2
Q1 2023	874,709	-57,924,448	-99%	01 Jan 2023	31 Mar 2023	10-Q	09 May 2024	2024	Q1
Q4 2022	874,234	+763	+0.09%	01 Oct 2022	31 Dec 2022	10-K	21 Mar 2024	2023	FY
Q3 2022	874,327	-57,709,149	-99%	01 Jul 2022	30 Sep 2022	10-Q	09 Nov 2023	2023	Q3
Q2 2022	58,815,543	+5,110,254	+9.5%	01 Apr 2022	30 Jun 2022	10-Q	03 Aug 2023	2023	Q2
Q1 2022	58,799,157	+10,232,051	+21%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q4 2021	873,471			01 Oct 2021	31 Dec 2021	8-K	21 Dec 2023
Q3 2021	58,583,476			01 Jul 2021	30 Sep 2021	10-Q	03 Nov 2022	2022	Q3
Q2 2021	53,705,289			01 Apr 2021	30 Jun 2021	10-Q	04 Aug 2022	2022	Q2
Q1 2021	48,567,106			01 Jan 2021	31 Mar 2021	10-Q	16 May 2022	2022	Q1

Dianthus Therapeutics, Inc. /DE/ Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	38,617,580	+5,303,731	+16%	01 Jan 2025	31 Dec 2025	10-K	09 Mar 2026	2025	FY
2024	33,313,849	+28,160,426	+546%	01 Jan 2024	31 Dec 2024	10-K	09 Mar 2026	2025	FY
2023	5,153,423	+4,279,189	+489%	01 Jan 2023	31 Dec 2023	10-K	11 Mar 2025	2024	FY
2022	874,234	+763	+0.09%	01 Jan 2022	31 Dec 2022	10-K	21 Mar 2024	2023	FY
2021	873,471	-43,046,650	-98%	01 Jan 2021	31 Dec 2021	8-K	21 Dec 2023
2020	43,920,121			01 Jan 2020	31 Dec 2020	10-K	08 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.